CURE vs GIND
Comparison between DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF) and Goldman Sachs India Equity ETF (GIND, ETF).
CURE vs GIND - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
CURE
$157M
Winner
GIND
$157M
Expense Ratio
CURE
N/A
GIND
0.75%
Max Drawdown
CURE
69.19%
Winner
GIND
22.97%
Sharpe Ratio
Winner
CURE
0.79
GIND
-1.09
5Y Beta
CURE
1.38
Winner
GIND
0.50
P/E Ratio
CURE
28.04
GIND
N/A
Forward P/E
CURE
18.09
GIND
N/A
5Y Dividends CAGR
CURE
63.21%
GIND
N/A
5Y EPS CAGR
CURE
12.58%
GIND
N/A
Debt to Equity
CURE
53.58%
GIND
N/A
P/S Ratio
CURE
1.48
GIND
N/A
P/B Ratio
CURE
4.58
GIND
N/A
CURE vs GIND - Holdings Comparison
CURE and GIND have 1 common holdings. Overlap is -3.15%
CURE's top 25 holdings weight is 91.92%. GIND's top 25 holdings weight is 50.47%.
| Rank | CURE | GIND |
|---|---|---|
| #1 | GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 12.35% | ICICI BANK LTD (n/a) - 5.44% |
| #2 | ELI LILLY AND CO (LLY) - 11.75% | HDFC BANK LTD (n/a) - 3.59% |
| #3 | DREYFUS GOVT CASH MAN INS (n/a) - 10.69% | RELIANCE INDUSTRIES LTD (n/a) - 2.97% |
| #4 | JOHNSON & JOHNSON (JNJ) - 7.72% | INFOSYS LTD (n/a) - 2.59% |
| #5 | GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.02% | AXIS BANK LTD (n/a) - 2.53% |
| #6 | ABBVIE INC (ABBV) - 5.24% | MAHINDRA & MAHINDRA LTD (n/a) - 2.42% |
| #7 | UNITEDHEALTH GROUP INC (UNH) - 4.75% | BAJAJ FINANCE LTD (n/a) - 2.39% |
| #8 | MERCK & CO INC (MRK) - 4.14% | TATA STEEL LTD (n/a) - 2.33% |
| #9 | AMGEN INC (AMGN) - 2.52% | KOTAK MAHINDRA BANK LTD (n/a) - 2.25% |
| #10 | THERMO FISHER SCIENTIFIC INC (TMO) - 2.34% | SUN PHARMACEUTICALS INDUSTRIES LTD (n/a) - 2.00% |
| #11 | GILEAD SCIENCES INC (GILD) - 2.31% | BHARTI AIRTEL LTD (n/a) - 1.91% |
| #12 | INTUITIVE SURGICAL INC (ISRG) - 2.16% | GRASIM INDUSTRIES LTD (n/a) - 1.81% |
| #13 | ABBOTT LABORATORIES (ABT) - 2.10% | STATE BANK OF INDIA (n/a) - 1.73% |
| #14 | PFIZER INC (PFE) - 2.05% | HINDALCO INDUSTRIES LTD (n/a) - 1.55% |
| #15 | BRISTOL-MYERS SQUIBB CO (BMY) - 1.65% | ETERNAL LTD (n/a) - 1.55% |
| #16 | CVS HEALTH CORP (CVS) - 1.61% | APOLLO HOSPITALS ENTERPRISE LTD (n/a) - 1.54% |
| #17 | VERTEX PHARMACEUTICALS INC (VRTX) - 1.54% | NESTLE INDIA LTD (n/a) - 1.49% |
| #18 | DANAHER CORP (DHR) - 1.51% | SAMVARDHANA MOTHERSON INTERNATIONAL LTD (n/a) - 1.45% |
| #19 | STRYKER CORP (SYK) - 1.50% | TATA CONSUMER PRODUCTS LTD (n/a) - 1.42% |
| #20 | MEDTRONIC PLC (MDT) - 1.38% | TVS MOTOR CO LTD (n/a) - 1.38% |
| #21 | MCKESSON CORP (MCK) - 1.29% | n/a (n/a) - 1.32% |
| #22 | BOSTON SCIENTIFIC CORP (BSX) - 1.19% | SBI LIFE INSURANCE CO LTD (n/a) - 1.27% |
| #23 | ELEVANCE HEALTH INC (ELV) - 1.19% | BHARAT ELECTRONICS LTD (n/a) - 1.25% |
| #24 | THE CIGNA GROUP (CI) - 1.03% | TORRENT PHARMACEUTICALS LTD (n/a) - 1.16% |
| #25 | REGENERON PHARMACEUTICALS INC (REGN) - 0.89% | TD POWER SYSTEMS LTD (n/a) - 1.13% |
| Total Holdings | 65 | 123 |
CURE vs GIND - Historical Returns
Returns include dividend reinvestment.
1M
Winner
CURE
+22.71%
GIND
-4.88%
3M
CURE
-2.64%
Winner
GIND
-1.78%
6M
Winner
CURE
+3.17%
GIND
-10.70%
1Y
Winner
CURE
+35.83%
GIND
-15.16%
5Y(CAGR)
CURE
+2.35%
GIND
N/A
10Y(CAGR)
CURE
+13.12%
GIND
N/A
Max(CAGR)
Winner
CURE
+23.37%
GIND
-6.65%
CURE vs GIND - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | CURE | GIND |
|---|---|---|
| 2026 | -7.73% | -12.60% |
| 2025 | +22.87% | +4.55% |
| 2024 | -12.90% | N/A |
| 2023 | -8.46% | N/A |
| 2022 | -17.91% | N/A |
| 2021 | +90.55% | N/A |
| 2020 | +4.13% | N/A |
| 2019 | +62.36% | N/A |
| 2018 | -0.75% | N/A |
| 2017 | +62.77% | N/A |
| 2016 | -12.42% | N/A |
| 2015 | +6.24% | N/A |
| 2014 | +83.03% | N/A |
| 2013 | +153.15% | N/A |
| 2012 | +45.79% | N/A |
| 2011 | -9.68% | N/A |
CURE vs GIND Drawdown Comparison
The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.
The maximum drawdown for GIND was -22.97%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current CURE drawdown is -25.85%. The current GIND drawdown is -16.41%.
| Rank | CURE | GIND |
|---|---|---|
| #1 | -69.19% Jan 22, 2020 - Jan 6, 2021 | -22.97% Jul 1, 2025 - Mar 30, 2026 |
| #2 | -52.25% Apr 8, 2022 - Aug 7, 2025 | -5.81% Apr 3, 2025 - Apr 15, 2025 |
| #3 | -48.54% Jul 20, 2015 - Jun 22, 2017 | -4.08% May 5, 2025 - May 13, 2025 |
| #4 | -44.44% Jul 1, 2011 - Mar 15, 2012 | -2.80% Jun 10, 2025 - Jun 26, 2025 |
| #5 | -42.27% Oct 1, 2018 - Nov 27, 2019 | -1.87% Apr 24, 2025 - May 5, 2025 |
| #6 | -36.35% Jan 26, 2018 - Sep 13, 2018 | -1.60% May 19, 2025 - Jun 6, 2025 |
| #7 | -29.28% Dec 30, 2021 - Apr 8, 2022 | -0.79% Jun 27, 2025 - Jul 1, 2025 |
| #8 | -22.89% Aug 17, 2021 - Dec 15, 2021 | -0.29% Apr 22, 2025 - Apr 24, 2025 |
| #9 | -22.59% Sep 24, 2014 - Oct 28, 2014 | -0.06% Apr 15, 2025 - Apr 17, 2025 |
| #10 | -19.78% Mar 4, 2014 - Jun 19, 2014 | -0.04% May 15, 2025 - May 19, 2025 |
| #11 | -19.31% Oct 17, 2012 - Jan 9, 2013 | N/A |
| #12 | -19.31% Jan 20, 2021 - Apr 15, 2021 | N/A |
| #13 | -17.38% Apr 2, 2012 - Jun 29, 2012 | N/A |
| #14 | -15.49% May 28, 2013 - Jul 12, 2013 | N/A |
| #15 | -14.96% Dec 8, 2014 - Jan 22, 2015 | N/A |
Correlation
Correlation between CURE and GIND is -0.24 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.24
-101
Select Stocks to Compare
Popular: CURE vs SPYGIND vs SPY
More Comparisons
Compare with similar stocks